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Background: Repair of aortic coarctation is often delayed in small infants because
of the belief that such patients are at risk of recurrent arch obstruction and that
growth will decrease this risk. To determine whether low weight was a risk factor
for recurrent arch obstruction, we reviewed our experience with coarctation repair
via left thoracotomy in infants less than 3 months of age.
Methods: From 1990 to 1999, 103 patients less than 3 months of age underwent
repair of aortic coarctation through a left thoracotomy. Median age was 18 days
(1-90 days), with 45 patients less than 2 weeks. Median weight was 3.3 kg (1.0-
6.4 kg) and 14 patients were less than 2 kg. The method of repair was resection
and end-to-end anastomosis in 64 patients, subclavian flap angioplasty in 34, and
patch augmentation of the arch in 5. Demographic, echocardiographic, and oper-
ative variables were analyzed for correlation with recurrent arch obstruction.
Results: One early and 1 late death occurred, both in patients who had complica-
tions but no evidence of recoarctation. At median follow-up of 24 months, reinter-
ventions for recurrent arch obstruction were performed in 15 patients. The median
time to reintervention was 5 months and was less than 1 year in 12 patients. Kaplan-
Meier freedom from arch reintervention was 88% at 1 year (95% confidence inter-
vals: 82%-94%) and 82% at 5 years (95% confidence intervals: 72%-92%). Factors
associated with shorter duration to arch reintervention by univariable Cox regres-
sion included younger age (continuous, P = .01; <2 weeks, P = .005), smaller trans-
verse arch (absolute diameter, P < .001; indexed to weight, P = .03; indexed to
ascending aortic diameter, P = .02), and smaller ascending aorta (absolute diame-
ter, P = .02). Smaller absolute transverse arch diameter and younger age were the
only independent predictors of shorter time to arch reintervention by multivariable
Cox regression analysis. Weight and type of repair did not correlate with risk of
recoarctation.
Conclusions: Low weight is not a risk factor for recurrent obstruction after repair of
coarctation of the aorta in infants less than 3 months of age. Rather, risk of recoarc-
tation is more a function of the anatomy of the arch. Thus, it is not indicated to delay
repair in low weight infants with the goal of achieving growth.
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One of the most common and importantadverse outcomes in patients undergoingrepair of aortic coarctation is recurrentarch obstruction. This is especially so inthe current era, because mortality afterrepair of isolated coarctation is almost
nonexistent in most large centers.1-13 Despite multiple stud-
ies focusing on the impact of technique of repair, few risk
factors for recurrent obstruction have been identified.7-16 It
is often thought that low weight neonates are at higher risk
for adverse outcome, including recurrent obstruction. This
belief may translate into a management approach aimed at
avoiding early repair in these patients, with medical man-
agement being used until somatic growth allows for a more
technically forgiving operative environment, with more
mature aortic tissue and a larger patient. However, no evi-
dence has been advanced to substantiate this approach. To
address the relationship between low weight and recurrent
arch obstruction, as well as to determine other factors that
might correlate with recoarctation, we retrospectively stud-
ied 103 consecutive patients less than 3 months of age who
had undergone repair of isolated aortic coarctation. 
Patients and Methods
Patients
From January 1990 through December 1999, 103 neonates and
infants less than 3 months of age underwent primary repair of aor-
tic coarctation through a left lateral thoracotomy. This does not
include patients in this age range who underwent repair of aortic
coarctation and associated anomalies through a median sternoto-
my. The group comprised 63 boys (61%) and 40 girls. Twenty-five
patients (24%) were born prematurely (≤35 weeks of estimated
gestational age), and 41% of patients were transferred to our insti-
tution directly in the newborn period, before postpartum discharge
home. Clear symptoms, including shock, feeding difficulties, or
respiratory distress, were present in 59% of patients. The diagno-
sis was made in 30 of the remaining patients after detection of
decreased pulses in the lower extremities with or without upper
extremity hypertension, or during evaluation of a murmur or cya-
notic episodes. In the 15 patients, some of whom were symptomatic
at the time of presentation, the diagnosis was made on the basis of
a fetal echocardiogram suggestive of aortic coarctation (n = 7; usu-
ally with small associated left heart structures) or on cardiovascu-
lar evaluation prompted by the existence of an associated genet-
ic/malformation syndrome (n = 8). An alprostadil (prostaglandin
E1) infusion was administered and maintained until the time of
repair in 40% of patients.
The median age at repair was 18 days (1-90 days). Repair was
performed at less than 1 month of age in 66% of patients (n = 68),
at less than 2 weeks in 44% (n = 45), and at less than 1 week in
22% (n = 23). The median weight was 3.3 kg (1.0-6.4 kg), with 14
(14%) patients weighing less than 2 kg and 7 (7%) less than 1.5 kg.
Associated cardiovascular anomalies and syndromes/noncardio-
vascular anomalies are summarized in Table 1. 
Surgical Management
All patients in this series underwent repair of aortic coarctation
through a left posterolateral thoracotomy, with no additional pro-
cedures. Aortic clamping was used without cardiopulmonary
bypass. The technique of repair varied according to era and the sur-
geon’s preference. The majority of patients underwent repair with
resection of the coarctation and end-to-end or extended end-to-end
anastomosis (n = 64, 62%), followed in frequency by subclavian
flap angioplasty (n = 34, 32%), end-to-end anastomosis with addi-
tional augmentation of the arch using a patch of allograft tissue (n
= 3, 3%), and patch aortoplasty (n = 2, 2%).
Echocardiographic Data
Preoperative echocardiograms were reviewed for each patient for
whom they were available (n = 95). In the remaining 8 patients,
preoperative echocardiography was not performed at our institu-
tion, and outside echocardiograms were not available for review at
the time the study was conducted. From images obtained in the
high-parasternal or suprasternal notch windows, diameters of the
ascending aorta and aortic arch were measured off-line as
described below and depicted in Figure 1. The diameter of the
ascending aorta was measured immediately proximal to the origin
of the first brachiocephalic vessel (innominate artery or common
brachiocephalic trunk). The diameter of the transverse arch was
measured between the left common carotid artery (or common bra-
chiocephalic trunk) and left subclavian artery. The diameter of the
aortic isthmus was measured at the site of the coarctation, or
immediately proximal to the entrance of the arterial duct if patent.
From a subcostal transverse image, the diameter of the descending
aorta at the level of the diaphragm was also measured. These aor-
tic diameters were indexed to the weight of the child at surgery.
They were also indexed to one another, to give ratios of transverse
arch to ascending aorta, isthmus to ascending aorta, and isthmus to
transverse arch.
Data Acquisition and Analysis
Preoperative and operative data were collected retrospectively by
reviewing patient records and the database of the Cardiac Center at
The Children’s Hospital of Philadelphia. Follow-up information
was obtained by contacting the cardiologist and/or family of the
patient, as approved by the Institutional Review Board for the
Protection of Human Subjects. Follow-up echocardiographic, sur-
gical, and catheterization-derived information was gathered from
the patient records and databases at our institution, or from the
referring cardiologist if the patient was followed up elsewhere.
Data are presented as mean ± standard deviation or median
(range), unless otherwise specified. The primary outcome measure
was reintervention for recurrent obstruction of the arch. Secondary
outcome measures were death and intervention for obstruction of
the aortic valve and/or subvalvular left ventricular outflow tract.
Independent variables assessed for correlation with these outcomes
are listed in Table 2. Estimates of postoperative freedom from rein-
tervention for recurrent arch obstruction, reinterventions on the
valvular/subvalvular left ventricular outflow tract, and survival
were obtained by the Kaplan-Meier product limit method and are
expressed as the mean with 95% confidence intervals (CI).
Univariable Cox proportional hazards regression was performed to
assess for independent variables associated with shorter postoper-
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ative freedom from arch reinterventions, shorter postoperative
freedom from other reinterventions, and decreased postoperative
survival. Factors found to be significant by univariable analysis,
with a P value ≤ .05, were entered into multivariable Cox regres-
sion analysis. On the basis of a recent study in which patients with
a surgical weight of less than 1.5 kg were found to have a signifi-
cantly shorter freedom from reintervention for recurrent arch
obstruction than patients between 1.5 and 2.0 kg at the time of
surgery,16 we also assessed outcomes, as described above, among
the cohort of patients weighing less than 2.0 kg. Results of Cox
regression analysis are presented in terms of odds ratio (OR) with
95% confidence intervals. Linear regression analysis was used to
test for correlation between continuous variables. SPSS for
Windows version 7.0 (SPSS, Inc, Chicago, Ill) was used for statis-
tical analysis.
Results
Demographic and Morphometric Associations
Age at repair, weight at repair, and technique of repair did
not differ significantly between the earlier and later parts of
our experience. No correlation existed between age and
weight at repair. Patients who were admitted directly as
neonates were significantly younger at the time of surgery
than those who were not (14.2 ± 18.5 vs 38.2 ± 25.7 days;
P < .001), and patients who were maintained on an
alprostadil infusion were significantly younger at the time
of surgery than those who were not (10.6 ± 12.6 vs 39.8 ±
25.6 days; P < .001). Premature infants underwent repair at
a significantly older age (37 ± 29 vs 26 ± 24 days; P = .05)
and lower weight (2.2 ± 0.9 vs 3.7 ± 0.9 kg; P < .001) than
term neonates. By linear regression, age as a continuous
variable correlated with the absolute diameter of the ascend-
ing aorta (r = 0.34, P = .001) and the absolute diameter of
the transverse arch (r = 0.39, P < .001). Weight as a contin-
uous variable correlated with the absolute diameter of the
ascending aorta (r = 0.33, P = .002), the absolute diameter
of the transverse arch (r = 0.47, P < .001), and the diameter
of the transverse arch indexed to weight (r = 0.76, P < .001). 
Survival
Cross-sectional follow-up data were available in all patients
and ranged from 5 months to 9.3 years (median 24 months)
after repair. Follow-up of at least 6 months was available on
all surviving patients, and all but 11 (n = 90, 89%) were fol-
lowed up for at least 1 year. There were 2 deaths during the
study period, both in low weight infants. There was 1 early
death in a patient born weighing 718 g at 28 weeks’ gesta-
tion, after a pregnancy complicated by twin-twin transfu-
sion in which the patient was the donor twin. The postnatal
course was complicated by necrotizing enterocolitis, and the
patient underwent coarctation repair at an age of 66 days
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TABLE 1.  Associated cardiovascular anomalies and genetic/congenital anomaly syndromes 
Associated anomaly/syndrome No. (%) of patients
Associated cardiovascular anomalies 89 (86%)
Bileaflet aortic valve 83 (81%)
Small ventricular septal defect 19 (18%)
Left-sided superior caval vein to the coronary sinus 15 (15%)
Valvular aortic stenosis* 7 (7%)
Structural/functional anomalies of mitral valve complex† 7 (7%)
Common brachiocephalic trunk 5 (5%)
Atrioventricular septal defect‡ 3 (3%)
Sinus venosus atrial septal defect 2 (2%)
Coronary sinus septal defect 1 (1%)
Associated genetic/congenital anomaly syndromes 14 (14%)
Turner syndrome 6 (6%)
Smith-Lemli-Optiz syndrome 1 (1%)
VACTERL association 1 (1%)
CHARGE association 1 (1%)
Trisomy 21 1 (1%)
Chromosome 15q deletion 1 (1%)
Partial chromosome 4 duplication 1 (1%)
Multiple noncardiac anomalies without identifiable syndrome 2 (2%)
VACTERL, Vertebral anomalies, anal atresia, cardiac abnormalities, tracheoesophageal fistula or esophageal atresia, renal agenesis and dysplasia, and
limb defects; CHARGE, coloboma, heart disease, atresia choanae, retarded growth and development and/or central nervous system anomalies, genital
hypoplasia, and ear anomalies and/or deafness.
*One patient had undergone prior balloon aortic valvuloplasty.
†Not including small valve size, decreased interpapillary distance, or common atrioventricular valve. Mitral valve anomalies included mild stenosis in 2
patients, moderate regurgitation in 2, double-orifice valve in 1, parachute valve in 1, and chordal attachments to the interventricular septum in 1.
‡Complete, transitional, and partial atrioventricular septal defect in 1 patient each.
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and a weight of 1.5 kg. After development of Escherichia
coli sepsis, she had a cardiopulmonary arrest and could not
be resuscitated. Echocardiographic examination before
death demonstrated a patent aortic arch with no obstruction.
The only other death occurred 5 months after repair in a pre-
mature infant (surgical weight 1.8 kg) with multiple con-
genital anomalies who had progressive bilateral pulmonary
vein stenosis ultimately necessitating support with extracor-
poreal membrane oxygenation. Catheterization in this
patient revealed a widely patent arch with no transanasto-
motic gradient. 
The Kaplan-Meier estimate of survival was 99% at 1
month (95% CI: 97%-100%) and 98% at 1 year (95% CI:
96%-100%) and beyond. By Cox regression analysis, none
of the independent variables analyzed was associated with
mortality.
Reinterventions for Recurrent Arch Obstruction
During the follow-up period, reinterventions for recurrent
coarctation were performed in 15 patients. Reintervention
was by transcatheter balloon arterioplasty in 14 patients and
surgical patch aortoplasty in 1. The median time to reinter-
vention was 5 months (2-42 months) and was less than 6
months in 10 (67%) patients, less than 1 year in 12 (80%),
and less than 2 years in 14 (93%). At the time of reinterven-
tion, the median gradient across the obstruction measured
during catheterization was 55 mm Hg (25 to 100 mm Hg).
The recurrent obstruction was located at the isthmus only in
11 patients, at the isthmus and the distal arch in 3, and at the
level of the distal arch only in 1. In 3 patients, the transverse
arch was hypoplastic as well. The obstruction was discrete
in 12 patients and over a long segment in 3. In all patients,
the reintervention was successful, with postdilation/postop-
erative pressure gradients less than 20 mm Hg and no need
for subsequent arch interventions at a median follow-up of
27 months (8-106 months) after reintervention.
The Kaplan-Meier estimate of freedom from reinterven-
tion for recurrent arch obstruction was 90% at 6 months
(95% CI: 84%-96%), 88% at 1 year (95% CI: 82%-94%),
and 82% at 5 years (95% CI: 72%-92%) (Figure 2). Factors
associated with shorter duration to recurrent coarctation by
univariable Cox regression analysis are presented in Table 2.
Notably, weight and prematurity did not correlate with risk
of recurrent obstruction. Of the 15 patients who underwent
reintervention, 12 were less than 2 weeks of age (80% vs
37% for patients not requiring reintervention; P = .002) and
11 had a transverse arch diameter of 3.5 mm or less (73% vs
11% for patients not requiring reintervention; P < .001)
(Figure 2). A smaller transverse arch diameter (multivari-
able OR = 3.0 [1.54-6.0]; P = .001) and younger age at
repair (multivariable OR = 1.06 [1.00-1.11]; P = .05) were
the only independent predictors of shorter time to reinter-
vention by multivariable Cox regression analysis. 
Among the 14 patients weighing less than 2 kg at the
time of repair, there was 1 early and 1 late death (described
above), and only 1 patient underwent reintervention for
recurrent arch obstruction. There were no significant differ-
ences in survival or freedom from reintervention for recur-
rent arch obstruction between patients weighing less than
1.5 kg and those weighing 1.5 to 2.0 kg at the time of repair.
Other Reinterventions
Six patients underwent reinterventions during the follow-up
period for valvular and/or subvalvular systemic outflow
tract obstruction, from 6 to 55 months after coarctation
repair. Two of these patients had undergone prior balloon
dilation for recurrent arch obstruction. Two patients had a
Ross or Ross-Konno procedure, 1 with complex valvular
and subvalvular obstruction and 1 with aortic regurgitation
as well as valvular aortic stenosis; 2 underwent resection of
subaortic stenosis, with gradients of 50 and 64 mm Hg; and
2 underwent transcatheter balloon valvuloplasty of the aor-
tic valve for peak gradients of 74 and 96 mm Hg. All of
these patients had a bileaflet aortic valve and 2 had evidence
of valvular aortic stenosis before coarctation repair, 1 of
whom had undergone balloon aortic valvuloplasty before
the coarctation was repaired. Freedom from intervention on
the valvular and/or subvalvular systemic outflow tract was
98% at 1 year (95% CI: 95%-100%) and 88% at 5 years
(95% CI: 77%-99%) after coarctation repair (Figure 3).
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Figure 1. Diagram depicting the sites on the high parasternal
echocardiographic image at which the diameters of the ascend-
ing aorta (AAo), transverse arch (TA), and isthmus were measured.
Also labeled are the left (L) common carotid (CCA) and subclavian
(SCA) arteries, the innominate artery (IA), and the descending
aorta (DAo). AR, Anterior and rightward; I, inferior; PL, posterior
and leftward; S, superior.
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None of the independent variables analyzed by Cox regres-
sion analysis was significantly associated with shorter time
to valvular/subvalvular reintervention.
Six other patients underwent interventions subsequent to
the coarctation repair for correction of atrioventricular sep-
tal defect (n = 3), sinus venosus atrial septal defect (n = 2),
or ventricular septal defect (n = 1) between 4 and 21 months
postoperatively. No mortality or significant morbidity was
associated with any of the reinterventions.
Discussion
The primary objectives of this study were to determine
whether low weight at the time of isolated coarctation
repair was associated with a greater risk of recurrent arch
obstruction and to identify other factors that correlated with
likelihood of recurrent obstruction. We focused on the rela-
tionship between low weight and outcome because, as
repair of congenital heart defects in the neonatal period has
become more common for many lesions, repair in prema-
ture and small infants has become an increasingly impor-
tant frontier. It has been suggested that premature and low
weight infants are at increased risk of poor outcome after
repair of congenital cardiovascular anomalies. Although
the management of such infants may be more complex than
with term neonates, early repair in premature and low
weight patients with hemodynamically important heart dis-
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TABLE 2. Results of univariable Cox regression analysis for factors associated with freedom from reintervention for recur-
rent arch obstruction
Independent variable OR (95% CI)* P value
Demographic variables
Age (continuous) 1.08 (1.02-1.14) .01
Age <2 weeks 6.3 (1.77-22.4) .005
Weight (continuous) 1.19 (0.74-1.82) .48
Weight <2 kg 0.51 (0.07-3.9) .52
Premature birth 0.22 (0.03-1.70) .15
Male sex 1.15 (0.41-3.3) .79
Associated anomalies
Valvular aortic stenosis 1.02 (0.13-7.8) .98
Bileaflet aortic valve 2.2 (0.29-17.4) .44
Ventricular septal defect 0.33 (0.04-2.6) .29
Abnormal mitral valve apparatus 1.09 (0.14-8.3) .93
Left superior caval vein 0.42 (0.05-3.2) .4
Common brachiocephalic trunk 3.2 (0.71-14.1) .14
Syndromes/multiple noncardiac anomalies 0.46 (0.06-3.6) .46
Morphometric variables
Ascending aorta diameter (absolute) 2.1 (1.14-3.8) .02
Ascending aorta diameter indexed to weight 1.34 (0.74-2.4) .48
Transverse arch diameter (absolute) 3.8 (2.0-7.4) <.001
Transverse arch diameter indexed to weight 7.9 (2.0-31.4) .04
Aortic isthmus diameter (absolute) 1.37 (0.80-2.3) .32
Aortic isthmus diameter indexed to weight 6.9 (0.00-2600) .65
Transverse arch/ascending aorta diameter ratio 20.2 (1.11-491) .02
Isthmus/ascending aorta diameter ratio 0.70 (0.01-40.9) .95
Isthmus/transverse arch diameter ratio 6.2 (0.01-4.1) .28
Clinical/surgical variables
Symptoms of coarctation present† 1.0 (0.56-1.6) .88
Diagnosis by fetal echocardiogram 1.5 (0.69-3.1) .31
Newborn diagnosis and admission‡ 1.6 (0.96-2.7) .07
Alprostadil infusion§ 1.7 (0.98-2.8) .06
Repair by subclavian flap angioplasty 1.43 (0.50-4.1) .5
Repair by end-to-end anastomosis 0.66 (0.29-1.87) .44
*OR (odds ratio) > 1 indicates shorter freedom from reintervention.
†Symptoms including shock, respiratory distress, and/or feeding difficulties.
‡Without prior discharge to home.
§Alprostadil (prostaglandin E1) infusion maintained until the time of coarctation repair.
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ease may be preferable to a more conservative approach
aimed at medical management while waiting for the patient
to grow.17 Among patients with hemodynamically signifi-
cant heart disease, metabolic demand can be substantially
elevated, and waiting for growth may not be an effective
strategy. In a recent report from our institution, for exam-
ple, low weight infants with hypoplastic left heart syn-
drome did not gain a significant amount of weight in the
preoperative period.18
We could not demonstrate any correlation between recur-
rent arch obstruction and weight at the time of repair, ana-
lyzed as continuous variables and compacted into several
dichotomous categories, or prematurity. Although weight
did correlate with the preoperative diameter of the trans-
verse arch, which was the strongest predictor of reinterven-
tion for recurrent arch obstruction, weight itself was not
related to outcome. However, both of the deaths in our series
occurred in premature infants, and although mortality was
not related to surgery or recurrent arch obstruction, low
weight and premature infants may still be at increased risk
of poor outcome. Moreover, despite our preference for early
repair even in low weight infants, premature infants in our
series underwent repair at a significantly older age than term
neonates and at a significantly lower weight, which suggests
that repair was delayed on the basis of prematurity or small
size in some of these patients.
In a recent review of 18 patients less than 2 kg undergo-
ing repair of critical coarctation of the aorta, Bacha and
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Figure 2. Kaplan-Meier curves for freedom from reintervention for recurrent arch obstruction. A, All patients; B,
stratified according to age at repair; C, stratified according to the diameter of the transverse arch (includes only
the 95 patients with preoperative echocardiographic data available).
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associates16 found weight less than 1.5 kg at the time of
repair to be the only independent predictor of recurrent or
residual arch obstruction. Eight of the 18 patients underwent
reintervention for residual (n = 6) or recurrent (n = 2) arch
obstruction, which differs markedly from our experience, in
which reintervention was performed in 1 of 14 patients who
weighed less than 2 kg at the time of the initial repair, with
no statistically significant difference between patients
weighing less than 1.5 kg and those weighing 1.5 to 2.0 kg.
Mortality after repair of isolated coarctation of the aorta
in neonates and young infants is minimal. In most recent
series, as well as our experience, fewer than 2% of patients
have died in the early postoperative period.1-13 As in other
forms of congenital heart disease, the decreasing mortality
associated with early repair of aortic coarctation brings
other outcome measures into sharper focus. In patients
undergoing early repair of coarctation, one of the most
important and most common adverse outcomes is recurrent
arch obstruction, which has been reported to occur in up to
30% of patients and is generally in the range of 10% to
20%.1-15
Despite the frequency and importance of recurrent arch
obstruction, few risk factors for this complication have
been identified. Fenchel and colleagues11 observed a
higher probability of recurrent obstruction in patients
undergoing repair with a continuous suture technique as
opposed to interrupted, and a worse outcome in patients
undergoing repair at less than 2 weeks of age. Similarly,
Van Heurn,3 Sanchez,14 and their associates found
younger age at repair to be a risk factor for recoarctation.
Wu and colleagues15 found the size of the transverse arch
to be associated with probability of recurrence. In these
reports and most others investigating risk factors for
recurrent arch obstruction after early coarctation repair,
the primary focus has been the relationship between the
technique of repair and recoarctation. On the whole, these
studies demonstrate that the incidence of recurrent
obstruction does not differ substantially between patients
undergoing repair with subclavian flap angioplasty and
resection with end-to-end anastomosis, although the prob-
ability of recoarctation appears to be higher after simple
patch aortoplasty, and 1 study found a lower probability
of recurrent obstruction in patients undergoing extended
end-to-end repair.7-15 Otherwise, published data on risk
factors for recoarctation are sparse. 
In the present study, we found the diameter of the trans-
verse arch and younger age at repair to be associated with
shorter time to reintervention for recurrent arch obstruction
by multivariable Cox regression analysis. Both of these risk
factors have been reported by others.3,11,14,15 The diameter
of the ascending aorta, the diameter of the transverse arch
indexed to weight and to the diameter of the ascending
aorta, and age less than 2 weeks were also significant by
univariable examination but not with multivariable analysis.
Younger age at the time of repair correlated with smaller
transverse arch diameter, but its association with recurrent
coarctation was independent of this effect, as evidenced by
the significance of both variables on multivariable Cox
regression analysis. It is likely that age is at least in part a
surrogate variable for severity of coarctation, inasmuch as
there was a trend toward shorter freedom from reinterven-
tion in patients admitted directly to our center during the
newborn period (ie, early diagnosis) and those in whom an
alprostadil infusion was maintained until the time of surgery
(ie, ductus-dependent). As with previous studies, we did not
find any difference in the rate of recurrent arch obstruction
according to the technique of repair. 
Almost all of the interventions for recurrent coarctation
in our series were performed within the first year after
repair. Others have found this to be the case as well.13,19 The
probable reason is that the rate of somatic growth is at its
highest during the first year of life. However, it is not clear
whether inadequate relief of the native obstruction or failure
of arch growth in some patients simply becomes obvious
during this period of rapid somatic growth or whether intrin-
sic abnormalities of the hypoplastic or surgically repaired
arch interfere with normal growth. Although this issue
deserves further study, it is important to note that none of
the patients who underwent reintervention, which was by
balloon dilation in all but 1 case, had subsequent recurrence
of arch obstruction. Thus, it does not appear that there are
intrinsic and persistent abnormalities of the arch that pre-
vent growth of the arch altogether in patients who required
a first arch reintervention. 
The Journal of Thoracic and Cardiovascular Surgery • Volume 122, Number 5   889
Figure 3. Kaplan-Meier curve for freedom from reinterventions for
obstruction of the valvular/subvalvular left ventricular outflow
tract. 
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Limitations of the Study
The primary outcome that we assessed was reintervention
for recurrent arch obstruction. One of the reasons that we
elected to analyze this variable rather than recurrent
obstruction per se is that some patients did not have
echocardiographic examinations at their most recent follow-
up. The presence of recurrent obstruction can be assessed by
several methods, including blood pressure gradients
between the upper and lower extremities by sphygmo-
manometry, peak instantaneous velocity across the arch by
Doppler echocardiography, or peak-to-peak pressure gradi-
ent between the arch and descending aorta with cardiac
catheterization. These techniques often yield substantially
different estimates, and the determination of “significant”
recurrent obstruction is somewhat arbitrary. Many clinicians
and investigators use 20 to 25 mm Hg as a threshold for
qualifying recurrent obstruction as significant, and all of the
patients who underwent reintervention in our study had at
least this degree of obstruction. However, aside from poten-
tial hemodynamic and metabolic consequences of recurrent
obstruction, reintervention is the most important variable
that can be assessed with certainty. Thus, although using
reintervention as the primary outcome measure may not be
a completely accurate estimate of significant recoarctation,
we do not believe that this limitation compromises the find-
ings of our study.
Because we did not routinely assess the residual gradient
across the anastomosis early after coarctation repair, we
were not able to analyze this variable as a potential risk fac-
tor for reintervention. This may be an important limitation if
the adequacy of the initial repair is a significant factor con-
tributing to later need for arch reintervention. Only 5 of the
patients who ultimately underwent arch reintervention had a
discharge echocardiogram to assess the repair. Two of these
had pressure gradients of more than 30 mm Hg, and gradi-
ents in the others were all less than 15 mm Hg.
As with most cross-sectional follow-up studies, the
duration of follow-up varied extensively among our
patients. Although Kaplan-Meier analysis accounts for the
variability of follow-up duration for time-related out-
comes, it is nevertheless possible that the incidence of
outcome events may be underestimated. In anticipation of
this consideration, we designed the study to allow for fol-
low-up of at least 6 months postoperatively. Follow-up
data of this duration were obtained for all survivors and
for at least 1 year in 89%. Two thirds of patients who
underwent reinterventions had these procedures per-
formed within 6 months of surgery and 80% within 1 year.
Thus, on the basis of our minimum follow-up duration of
6 months, a strong trend toward reinterventions within 1
year of surgery, and the statistical methods used, our
analysis is unlikely to be dramatically skewed.
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